Among these 2 cohorts, 15.3% (84/549) of the astrocytoma, IDH-mut and 8.87% (328/3695) of the glioblastoma, IDH-WT samples displayed ≥1 mutation of 17 CR genes that were considered (Table 1). This evidence concerns the gene IDH1 and glioblastoma.